Pharco Corporation Egypt
@pharcoc
Pharco Pharmaceuticals is one of the dominant players in the pharmaceutical industry in Egypt, the Middle East, and Africa.
ID: 1400828914377773059
https://www.pharco.org/ 04-06-2021 14:57:11
332 Tweet
251 Followers
305 Following
TAG applauds World Health Organization (WHO)'s decision to add ravidasvir to its Essential Medicines List for treatment of hepatitis C Virus (HCV) in adults. Now, governments and health systems must tackle remaining barriers to HCV care. Our statement: treatmentactiongroup.org/statement/tag-…
World Health Organization (WHO) lists Malaysian-developed #hepatitisC drug as essential medicine. “This addition to the list would mean many more member states and civil society groups can gain access to this affordable medicine and eliminate hepatitis C by 2030” Noor Hisham Abdullah freemalaysiatoday.com/category/natio… Foon Fong Loh
World Health Organization (WHO) congratulates Egypt for becoming the 1st country to achieve Gold Tier status on the path to elimination of hepatitis C. Achieving the gold tier means that 🇪🇬fulfilled the requirements that reduce new infections & deaths to levels that position the country to end the epidemic
WHO Egypt World Health Organization (WHO) WHO Regional Office for the Eastern Mediterranean UNIC Cairo Fantastic news! Egypt is a leader among nations to end Hepatitis by 2030
Honored to meet his Excellency, President of #Egypt Abdelfattah Elsisi, to congratulate him on 🇪🇬's world-leading work to protect people from #Hepatitis C and present him with the first validation of a country by World Health Organization (WHO) to achieve Gold Tier status in its path to eliminate Hepatitis C.
The political commitment and commitment at all levels including health workers & communities was instrumental in #Egypt becoming the first to achieve World Health Organization (WHO) Gold Tier status on the path to eliminate #Hepatitis C, by screening 87% of Egyptians & treating 93% needing care, well above
Egypt becomes the first country to achieve WHO validation on the path to elimination of hepatitis C emro.who.int/media/news/egy… #LiverTwitter #IDTwitter #NoHep WHO Regional Office for the Eastern Mediterranean
Last month saw a significant milestone for #hepatitisC patients in 🇹🇭! We signed a MoU of ‘Collaborative and License Agreement’ with Mahidol University and Pharco Corporation Egypt to license ravidasvir for treatment of #HCV patients in Thailand. #access2treatment Pharmacy Mahidol U. 📖 dndi.org/news/2024/ravi…
📝When the first #HepatitisC treatment launched in 2013, it cost USD 84,000. Today, #ravidasvir—born from South-South collaboration—is changing the game. An MoU signed with องค์การเภสัชกรรม and Pharco Corporation Egypt aims to register this effective and affordable treatment in Thailand.